Review: taking Uloric and Diovan together


Summary

Drug interactions are reported among people who take Uloric and Diovan together. This review analyzes the effectiveness and drug interactions between Uloric and Diovan. It is created by eHealthMe based on reports of 57 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Uloric and Diovan >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Uloric

Uloric has active ingredients of febuxostat. It is often used in gout. (latest outcomes from Uloric 955 users)

Diovan

Diovan has active ingredients of valsartan. It is often used in high blood pressure. (latest outcomes from Diovan 53,329 users)

On Aug, 24, 2016

57 people who take Uloric, Diovan are studied.


Number of reports submitted per year:

Uloric and Diovan drug interactions.

Drug effectiveness over time:

Uloric:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Diovan:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Uloric:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (2 of 2 people)
Diovan:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Uloric:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)
Diovan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • toxic epidermal necrolysis
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • diabetes mellitus
  • febrile neutropenia
  • generalised oedema
  • arteriovenous fistula
  • conjunctivitis
  • dermatitis bullous
  • diplopia
1 - 6 months:
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • anxiety
  • diabetes mellitus
  • diabetic ketoacidosis
  • dizziness
  • febrile neutropenia
  • generalised oedema
  • hyperglycaemia
  • activated partial thromboplastin time prolonged
1 - 2 years:
  • pancreatitis chronic
2 - 5 years:
  • dizziness
  • anxiety
  • fall
  • haemorrhage intracranial
  • head injury
  • myositis
  • pancreatitis chronic
  • rib fracture
5 - 10 years:
  • dizziness
not specified:
  • diarrhoea
  • dizziness
  • asthenia
  • headache
  • rhinorrhoea
  • dehydration
  • fatigue
  • nausea
  • palpitations
  • fall

Most common drug interactions by gender *:

female:
  • diarrhoea
  • rhinorrhoea
  • palpitations
  • toxic epidermal necrolysis
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • asthenia
  • blood uric acid increased
  • deep vein thrombosis
  • diabetes mellitus
male:
  • dizziness
  • asthenia
  • fall
  • hypotension
  • anaemia
  • anxiety
  • back pain
  • dehydration
  • diabetic ketoacidosis
  • diarrhoea

Most common drug interactions by age *:

2-9:
  • back pain
20-29:
  • diabetic ketoacidosis
  • hyperglycaemia
30-39:
  • fatigue
40-49:
  • dizziness
  • nausea
50-59:
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • anxiety
  • diabetes mellitus
  • dizziness
  • febrile neutropenia
  • generalised oedema
  • acne
  • haemorrhoids
  • psoriasis
60+:
  • diarrhoea
  • dizziness
  • rhinorrhoea
  • asthenia
  • fall
  • headache
  • palpitations
  • toxic epidermal necrolysis
  • anaemia
  • blood uric acid increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Uloric and Diovan?

Can you answer these questions?

More questions for: Uloric, Diovan

You may be interested in these reviews

More reviews for: Uloric, Diovan

On eHealthMe, Uloric (febuxostat) is often used to treat gout. Diovan (valsartan) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.